Trial Profile
Dose-finding Study of SPP100 in Essential Hypertension
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2010
Price :
$35
*
At a glance
- Drugs Aliskiren (Primary)
- Indications Essential hypertension
- Focus Therapeutic Use
- Sponsors Novartis
- 05 Nov 2010 New trial record.